Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2 [EARLY_Phase 1]
Phase 1 trial update assessing biodistribution and safety of PET probes [18F]FPRGD2 and [18F]FPPRGD2 in cancer patients; results posted afte…
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: The p53 Breast Cancer Trial [Phase 2]
Phase 2 clinical trial update for a p53-targeted breast cancer study, currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and Mastectomy [Phase 3]
A Phase 3 trial evaluating the necessity of post-mastectomy radiotherapy after neoadjuvant chemotherapy and mastectomy for breast cancer; st…
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting.
A completed clinical trial evaluating treatment patterns and clinical outcomes for HR+/HER2- metastatic breast cancer patients treated with …
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer [Phase 2]
A Phase 2 trial evaluated microwave ablation combined with camrelizumab for early breast cancer and has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial PROCLAIM-CX-2009 evaluating safe and active doses of CX-2009 for selected solid tumors; trial status terminated with results…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Evaluation of Safety and Efficacy of Sodium Thiosulfate (BYON5667) Eye Drops to Reduce Ocular Toxicity in Cancer Patients Treated With SYD985 [Phase 1, Phase 2]
A phase 1/2 trial evaluating sodium thiosulfate eye drops (BYON5667) to reduce ocular toxicity in cancer patients treated with SYD985 has co…
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine [Phase 2]
Phase 2 clinical trial assessing the effect of topical diclofenac on outcomes in breast cancer patients treated with capecitabine for Hand a…
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer [Phase 3]
Phase 3 trial of CN-Trastuzumab (SIBP-01) with docetaxel and carboplatin in HER2-positive early breast cancer completed.
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: PTC Guiding Neoadjuvant Treatment in Breast Cancer [Phase 2]
Phase 2 clinical trial update examining preoperative therapy guidance in breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis [Phase 2]
Phase 2 trial assessing atezolizumab plus stereotactic radiation for triple-negative breast cancer with brain metastases has completed enrol…
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer [Phase 3]
Phase 3 trial results for S1207, comparing hormone therapy with and without everolimus, in breast cancer have been posted.
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel and cyclophosphamide with or without trastuzumab before surgery in untreated breast cancer; results were…
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: A Study of RC48-ADC in Subjects With Advanced Breast Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating RC48-ADC in subjects with advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast [Phase 2]
Phase 2 clinical trial investigating neratinib's effect on live cell HER2 signaling in triple negative breast cancer contexts.
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery [Phase 2]
Phase 2 clinical trial investigating TPIV100 in combination with sargramostim for HER2-positive breast cancer with residual disease after ch…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Study of the ICG Distribution in the Margins of Breast Cancer After Tumorectomy [Phase 2]
Phase 2 clinical trial assessing indocyanine green (ICG) distribution in the margins after tumor resection for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: 68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating 68-Ga-RM2 PET/MRI for imaging estrogen receptor-positive breast cancer has completed with results post…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Palbociclib After CDK and Endocrine Therapy (PACE) [Phase 2]
Phase 2 trial update of Palbociclib for metastatic breast cancer after CDK and endocrine therapy. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Cancer [Phase 2]
Phase 2 trial comparing oral AZD9833 (camizestrant) with intramuscular fulvestrant in postmenopausal women with advanced ER-positive HER2-ne…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery [Phase 3]
Phase 3 trial evaluating palbociclib added to standard endocrine therapy in HR-positive, HER2-normal breast cancer with residual disease aft…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients [Phase 2]
Phase II trial evaluating combination immunotherapy with NeuVax and Trastuzumab in high-risk HER2-positive breast cancer completed with resu…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant [Phase 2]
Phase 2 trial evaluating safety and efficacy of adding dapagliflozin to extended-release metformin versus metformin XR alone in HR+, HER2-, …
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease [Phase 2]
Phase 2 clinical trial evaluating intra-hepatic chemotherapy for liver metastases from breast cancer with limited extrahepatic disease has c…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer [Phase 3]
Phase 3 trial evaluating elacestrant versus standard of care for ER+/HER2- advanced breast cancer has completed, with results posted.